GOSS Return on Tangible Equity | GOSSAMER BIO, INC.

GOSSAMER BIO, INC. (GOSS) Return on Tangible Equity

2026-06-30: Return Tang Equity 133.17%.
2026-03-31: Return Tang Equity 111.71%.
2025-12-31: Return Tang Equity 138.78%.
2025-09-30: Return Tang Equity 189.67%.

Complete source-backed return tang equity history.

Available history: 2017-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	133.17%
2026-03-31	111.71%
2025-12-31	138.78%
2025-09-30	189.67%
2025-06-30	300.92%
2025-03-31	819.81%
2024-12-31	-191.67%
2024-09-30	-132.35%
2024-06-30	-99.17%
2024-03-31	-645.83%
2023-12-31	-286.47%
2023-09-30	-179.16%
2023-06-30	329.28%
2023-03-31	775.79%
2022-12-31	-1899.30%
2022-09-30	-407.98%
2022-06-30	1401.99%
2022-03-31	-776.38%
2021-12-31	-192.65%
2021-09-30	-142.70%
2021-06-30	-108.70%
2021-03-31	-90.75%
2020-12-31	-75.89%
2020-09-30	-62.74%
2020-06-30	-53.33%
2020-03-31	-65.84%
2019-12-31	-51.15%
2019-09-30	-41.22%
2019-06-30	-37.45%
2019-03-31	-31.97%
2018-12-31	122.40%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	138.78%
2024-12-31	-191.67%
2023-12-31	-286.47%
2022-12-31	-1899.30%
2021-12-31	-192.65%
2020-12-31	-75.89%
2019-12-31	-51.15%
2018-12-31	122.40%
2017-12-31	98.67%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Cogent Biosciences, Inc. (COGT)	United States	$5.450B	-17.61
PTC THERAPEUTICS, INC. (PTCT)	United States	$5.199B	-177.07
Dianthus Therapeutics, Inc. /DE/ (DNTH)	United States	$5.082B	-27.79
Erasca, Inc. (ERAS)	United States	$5.073B	-19.96
Oruka Therapeutics, Inc. (ORKA)	United States	$5.663B	-43.76
Travere Therapeutics, Inc. (TVTX)	United States	$5.712B	-123.10
Mirum Pharmaceuticals, Inc. (MIRM)	United States	$5.798B	-8.81
Veradermics, Inc (MANE)	United States	$4.839B
Edgewise Therapeutics, Inc. (EWTX)	United States	$4.470B	-22.23
Amneal Pharmaceuticals, Inc. (AMRX)		$6.326B	25.62